These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 17875000)

  • 1. Telomerase reverse transcriptase haploinsufficiency and telomere length in individuals with 5p- syndrome.
    Du HY; Idol R; Robledo S; Ivanovich J; An P; Londono-Vallejo A; Wilson DB; Mason PJ; Bessler M
    Aging Cell; 2007 Oct; 6(5):689-97. PubMed ID: 17875000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of TERC haploinsufficiency on the inheritance of telomere length.
    Goldman F; Bouarich R; Kulkarni S; Freeman S; Du HY; Harrington L; Mason PJ; Londoño-Vallejo A; Bessler M
    Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17119-24. PubMed ID: 16284252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous telomerase deficiency in mouse and man: when less is definitely not more.
    Mason PJ; Bessler M
    Cell Cycle; 2004 Sep; 3(9):1127-9. PubMed ID: 15326392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere restoration and extension of proliferative lifespan in dyskeratosis congenita fibroblasts.
    Westin ER; Chavez E; Lee KM; Gourronc FA; Riley S; Lansdorp PM; Goldman FD; Klingelhutz AJ
    Aging Cell; 2007 Jun; 6(3):383-94. PubMed ID: 17381549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the telomerase reverse transcriptase gene and haploinsufficiency of telomere maintenance in Cri du chat syndrome.
    Zhang A; Zheng C; Hou M; Lindvall C; Li KJ; Erlandsson F; Björkholm M; Gruber A; Blennow E; Xu D
    Am J Hum Genet; 2003 Apr; 72(4):940-8. PubMed ID: 12629597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA component, TERC.
    Gourronc FA; Robertson mM; Herrig AK; Lansdorp PM; Goldman FD; Klingelhutz AJ
    Exp Dermatol; 2010 Mar; 19(3):279-88. PubMed ID: 19558498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomeres and marrow failure.
    Calado RT
    Hematology Am Soc Hematol Educ Program; 2009; ():338-43. PubMed ID: 20008219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita.
    Armanios M; Chen JL; Chang YP; Brodsky RA; Hawkins A; Griffin CA; Eshleman JR; Cohen AR; Chakravarti A; Hamosh A; Greider CW
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15960-4. PubMed ID: 16247010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.
    Vulliamy T; Marrone A; Szydlo R; Walne A; Mason PJ; Dokal I
    Nat Genet; 2004 May; 36(5):447-9. PubMed ID: 15098033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyskeratosis congenita: telomerase, telomeres and anticipation.
    Marrone A; Walne A; Dokal I
    Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations.
    Marrone A; Sokhal P; Walne A; Beswick R; Kirwan M; Killick S; Williams M; Marsh J; Vulliamy T; Dokal I
    Haematologica; 2007 Aug; 92(8):1013-20. PubMed ID: 17640862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex.
    Vulliamy TJ; Dokal I
    Biochimie; 2008 Jan; 90(1):122-30. PubMed ID: 17825470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase RNA mutated in autosomal dyskeratosis congenita reconstitutes a weakly active telomerase enzyme defective in telomere elongation.
    Cerone MA; Ward RJ; Londoño-Vallejo JA; Autexier C
    Cell Cycle; 2005 Apr; 4(4):585-9. PubMed ID: 15753647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.
    Batista LF; Pech MF; Zhong FL; Nguyen HN; Xie KT; Zaug AJ; Crary SM; Choi J; Sebastiano V; Cherry A; Giri N; Wernig M; Alter BP; Cech TR; Savage SA; Reijo Pera RA; Artandi SE
    Nature; 2011 May; 474(7351):399-402. PubMed ID: 21602826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.
    Vulliamy TJ; Knight SW; Mason PJ; Dokal I
    Blood Cells Mol Dis; 2001; 27(2):353-7. PubMed ID: 11259155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
    Marrone A; Dokal I
    Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity.
    Hao LY; Armanios M; Strong MA; Karim B; Feldser DM; Huso D; Greider CW
    Cell; 2005 Dec; 123(6):1121-31. PubMed ID: 16360040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyskeratosis congenita -- a disease of dysfunctional telomere maintenance.
    Mason PJ; Wilson DB; Bessler M
    Curr Mol Med; 2005 Mar; 5(2):159-70. PubMed ID: 15974869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation.
    Vulliamy TJ; Marrone A; Knight SW; Walne A; Mason PJ; Dokal I
    Blood; 2006 Apr; 107(7):2680-5. PubMed ID: 16332973
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.